Clinical Trial Update: Daunorubicin + Cytarabine + Venetoclax in de Novo AML [NA]

View source ↗

Summary

This entry notes a clinical trial evaluating daunorubicin, cytarabine, and venetoclax in newly diagnosed acute myeloid leukemia, with enrollment by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Daunorubicin (daunorubicin)
• Venetoclax (venetoclax)

Snippet

Sponsor: Anhui Medical University | Conditions: Leukemia, Myeloid, Acute, Acute Myeloid Leukemia | NA | Status: ENROLLING_BY_INVITATION